Medicare Enrolled
Dr. Christopher Woodard, M.D.
Urology Physician · Lancaster, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Woodard from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Woodard?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Woodard
Dr. Christopher Woodard is an urology physician in Lancaster, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Woodard performed 7,571 Medicare services across 2,382 unique beneficiaries.
Between the years covered by Open Payments, Dr. Woodard received a total of $4,739 from 46 pharmaceutical and/or device companies across 243 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Woodard is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 5% volume in PA
$4,739 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,571
Medicare services
Top 5% in PA for urology physician
2,382
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~379 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
4,636 | $0 | $3 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
776 | $89 | $210 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
644 | $2 | $15 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
362 | $67 | $139 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
160 | $77 | $316 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
123 | $3 | $20 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
109 | $8 | $41 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
97 | $123 | $323 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
88 | $57 | $585 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
87 | $38 | $84 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
56 | $64 | $201 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
55 | $58 | $476 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
51 | $82 | $210 |
| Lower leg neurostimulator electrode insertion A procedure to place an electrode in the lower leg for neurostimulation therapy. |
49 | $88 | $315 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
45 | $189 | $800 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
43 | $40 | $249 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
36 | $8 | $15 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
34 | $64 | $553 |
| PSA test (prostate cancer screening) | 27 | $18 | $120 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
26 | $19 | $260 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
20 | $103 | $327 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
18 | $113 | $588 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
15 | $314 | $1,004 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
14 | $182 | $904 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
66.2% medium
33.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,739
Total received (2018-2024)
Avg $677/year across 7 years
Top 29% in PA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
243
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,739 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,151
2023
$1,012
2022
$837
2021
$575
2020
$274
2019
$500
2018
$390
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$315
ABBVIE INC.
$170
PFIZER INC.
$143
Merck Sharp & Dohme LLC
$111
SUN PHARMACEUTICAL INDUSTRIES INC.
$82
Astellas Pharma US Inc
$62
Teleflex LLC
$59
Bayer Healthcare Pharmaceuticals Inc.
$52
Telix Pharmaceuticals
$42
UROGEN PHARMA, INC.
$32
Ambu Inc.
$24
Myriad Genetic Laboratories, Inc.
$20
Sumitomo Pharma America, Inc.
$19
PROGENICS PHARMACEUTICALS, INC.
$18
Top 3 companies account for 54.6% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$768
PFIZER INC.
$693
Janssen Biotech, Inc.
$583
Merck Sharp & Dohme LLC
$291
Boston Scientific Corporation
$289
ABBVIE INC.
$170
UROVANT SCIENCES INC
$165
BOSTON SCIENTIFIC CORPORATION
$99
UroGen Pharma, Inc.
$97
Olympus America Inc.
$84
Bayer Healthcare Pharmaceuticals Inc.
$83
Axonics, Inc.
$83
Bayer HealthCare Pharmaceuticals Inc.
$83
SUN PHARMACEUTICAL INDUSTRIES INC.
$82
Progenics Pharmaceuticals, Inc.
$81
Agiliti Surgical, Inc.
$73
Novartis Pharmaceuticals Corporation
$70
Sun Pharmaceutical Industries Inc.
$68
Sumitomo Pharma America, Inc.
$66
Ferring Pharmaceuticals Inc.
$65
Teleflex LLC
$59
Telix Pharmaceuticals
$59
AbbVie, Inc.
$54
Myovant Sciences Inc.
$53
Merck Sharp & Dohme Corporation
$38
Laborie Medical Technologies Corp.
$36
ConvaTec Inc.
$34
Myriad Genetic Laboratories, Inc.
$33
Verity Pharmaceuticals Inc.
$33
UROGEN PHARMA, INC.
$32
Dendreon Pharmaceuticals LLC
$31
AbbVie Inc.
$30
Ambu Inc.
$24
Antares Pharma, Inc.
$24
Allergan, Inc.
$23
Coloplast Corp
$21
Blue Earth Diagnostics Limited
$21
Caldera Medical, Inc
$21
Baxter Healthcare
$20
AstraZeneca Pharmaceuticals LP
$20
PROGENICS PHARMACEUTICALS, INC.
$18
Kowa Pharmaceuticals America, Inc.
$15
BAXTER HEALTHCARE
$15
Accord Healthcare, Inc.
$12
E.R. Squibb & Sons, L.L.C.
$12
Ethicon US, LLC
$11
Top 3 companies account for 43.1% of all-time payments
Associated products mentioned in payments ›
Androgel · Axonics · Axonics r-SNM System · BOTOX · Balversa · CAMCEVI · Desara · ECHELON FLEX Stapler · ERLEADA · Erleada · FIRMAGON · Flexiva · GEMTESA · GENERAL - KIDNEY STONE DISEASE · GENTLECATH · ILLUCCIX · JELMYTO · KEYTRUDA · LITHOVUE · LYNPARZA · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Nubeqa · OPDIVO · ORGOVYX · PLUVICTO · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Prolaris · SUTENT · Seglentis · Sonablate · SpeediCath · TISSEEL · Trelstar · UGN Laser Capital · UROLIFT · XTANDI · XYOSTED · Xtandi · YONSA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
48
Per 100K population
8.6
County median income
$83,703
Nearest hospital
PENN STATE HEALTH LANCASTER MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Woodard is a clinical cardiology specialist, with above-average Medicare volume (top 5% in PA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Woodard experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Woodard performed 4,636 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Woodard receive payments from pharmaceutical companies?
Yes. Dr. Woodard received a total of $4,739 from 46 companies across 243 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Woodard's costs compare to other urology physicians in Lancaster?
Dr. Woodard's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Woodard) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Lancaster
Browse urology physicians in Lancaster ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in PA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in PA
Which PA urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology